[
  {
    "ts": "2025-08-12T06:57:38+00:00",
    "headline": "Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise",
    "summary": "Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.",
    "url": "https://www.pharmavoice.com/news/puerto-rico-biotech-manufacturing-hub-innovation-cytoimmune/757283/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "d33d3929-771d-35f5-b401-b9e2126b4930",
      "content": {
        "id": "d33d3929-771d-35f5-b401-b9e2126b4930",
        "contentType": "STORY",
        "title": "Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise",
        "description": "",
        "summary": "Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.",
        "pubDate": "2025-08-12T06:57:38Z",
        "displayTime": "2025-08-12T06:57:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/c6c4d449845702d6ebf21dad5504719b",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3inup2tbzSQmdDAZTlur1g--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/c6c4d449845702d6ebf21dad5504719b.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v4EkWZdGXk61oISf4h3D3g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/c6c4d449845702d6ebf21dad5504719b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/puerto-rico-biotech-manufacturing-hub-innovation-cytoimmune/757283/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/puerto-rico-ongoing-journey-manufacturing-065738844.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-12T00:20:05+00:00",
    "headline": "Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint. It proved a clinically meaningful and statistically significant improvement in overall survival for patients with FGFR2b-overexpressing, metastatic, or unresectable gastric/gastroesophageal junction cancer treated with bemarituzumab […]",
    "url": "https://finance.yahoo.com/news/amgen-announces-bemarituzumab-successful-phase-002005371.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9411423b-0f13-33f6-b6d6-e37e1f24eb9d",
      "content": {
        "id": "9411423b-0f13-33f6-b6d6-e37e1f24eb9d",
        "contentType": "STORY",
        "title": "Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint. It proved a clinically meaningful and statistically significant improvement in overall survival for patients with FGFR2b-overexpressing, metastatic, or unresectable gastric/gastroesophageal junction cancer treated with bemarituzumab […]",
        "pubDate": "2025-08-12T00:20:05Z",
        "displayTime": "2025-08-12T00:20:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Amgen Announces Bemarituzumab's Successful Phase 3 Results in FGFR2b+ Gastric Cancer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fl9k_iPg0JyfVI.qZJRd8A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RgojEqpZ8ITlaPGpQimL8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-announces-bemarituzumab-successful-phase-002005371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-announces-bemarituzumab-successful-phase-002005371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]